PT3277266T - Forma de dosagem oral sólida de amlodipina e usos veterinários da mesma - Google Patents
Forma de dosagem oral sólida de amlodipina e usos veterinários da mesmaInfo
- Publication number
- PT3277266T PT3277266T PT167138908T PT16713890T PT3277266T PT 3277266 T PT3277266 T PT 3277266T PT 167138908 T PT167138908 T PT 167138908T PT 16713890 T PT16713890 T PT 16713890T PT 3277266 T PT3277266 T PT 3277266T
- Authority
- PT
- Portugal
- Prior art keywords
- amlodipine
- dosage form
- solid dosage
- oral solid
- veterinary uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/057194 WO2016155815A1 (en) | 2015-04-01 | 2015-04-01 | Oral solid dosage form of amlodipine and veterinary uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3277266T true PT3277266T (pt) | 2021-04-19 |
Family
ID=52774265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167138908T PT3277266T (pt) | 2015-04-01 | 2016-03-31 | Forma de dosagem oral sólida de amlodipina e usos veterinários da mesma |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11147804B2 (pt) |
| EP (1) | EP3277266B1 (pt) |
| AU (1) | AU2016239689B2 (pt) |
| CA (1) | CA2981112C (pt) |
| DK (1) | DK3277266T3 (pt) |
| ES (1) | ES2866029T3 (pt) |
| PL (1) | PL3277266T3 (pt) |
| PT (1) | PT3277266T (pt) |
| SI (1) | SI3277266T1 (pt) |
| WO (2) | WO2016155815A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS228917B2 (en) | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| US6521647B2 (en) * | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
| BR0206644A (pt) * | 2001-01-26 | 2004-02-25 | Schering Corp | Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares |
| KR100604034B1 (ko) * | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
| EP1833466A1 (en) | 2004-12-28 | 2007-09-19 | Ranbaxy Laboratories Limited | Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine |
| US20090117197A1 (en) * | 2005-03-21 | 2009-05-07 | Vicus Therapeutics Llc | Compositions and methods for ameliorating cachexia |
| WO2008062435A2 (en) * | 2006-08-15 | 2008-05-29 | Alkem Laboratories Ltd. | Stabilised dosage forms of amlodipine besylate |
| WO2009110010A2 (en) * | 2008-03-07 | 2009-09-11 | Sun Pharmaceutical Industries Ltd. | Stable oral dosage form |
| WO2011102702A2 (en) * | 2010-02-16 | 2011-08-25 | Krka, D. D., Novo Mesto | Process for the preparation of oral solid dosage forms comprising valsartan |
| IT1400309B1 (it) * | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| US9446032B2 (en) * | 2011-08-26 | 2016-09-20 | Wockhardt Limited | Methods for treating cardiovascular disorders |
| DK2811998T3 (en) * | 2012-02-06 | 2019-02-25 | Merial Inc | PARASITICIDE ORAL VETERINARY COMPOSITIONS COMPREHENSIVE SYSTEMIC ACTIVATING ACTIVITIES, PROCEDURES AND APPLICATIONS THEREOF |
-
2015
- 2015-04-01 WO PCT/EP2015/057194 patent/WO2016155815A1/en active Application Filing
-
2016
- 2016-03-31 AU AU2016239689A patent/AU2016239689B2/en active Active
- 2016-03-31 SI SI201631158T patent/SI3277266T1/sl unknown
- 2016-03-31 EP EP16713890.8A patent/EP3277266B1/en active Active
- 2016-03-31 PL PL16713890T patent/PL3277266T3/pl unknown
- 2016-03-31 CA CA2981112A patent/CA2981112C/en active Active
- 2016-03-31 ES ES16713890T patent/ES2866029T3/es active Active
- 2016-03-31 PT PT167138908T patent/PT3277266T/pt unknown
- 2016-03-31 DK DK16713890.8T patent/DK3277266T3/da active
- 2016-03-31 US US15/563,300 patent/US11147804B2/en active Active
- 2016-03-31 WO PCT/EP2016/057172 patent/WO2016156550A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016239689A1 (en) | 2017-10-19 |
| SI3277266T1 (sl) | 2021-07-30 |
| US20180117023A1 (en) | 2018-05-03 |
| AU2016239689B2 (en) | 2021-06-24 |
| DK3277266T3 (da) | 2021-04-12 |
| US11147804B2 (en) | 2021-10-19 |
| WO2016155815A1 (en) | 2016-10-06 |
| CA2981112C (en) | 2024-02-06 |
| ES2866029T3 (es) | 2021-10-19 |
| WO2016156550A1 (en) | 2016-10-06 |
| PL3277266T3 (pl) | 2021-07-05 |
| CA2981112A1 (en) | 2016-10-06 |
| EP3277266B1 (en) | 2021-02-17 |
| EP3277266A1 (en) | 2018-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251153A1 (zh) | 一種藥物組合物及其應用 | |
| ZA201704985B (en) | Oral care compositions and methods of use | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| HK1249103B (zh) | 多環氨甲醯基吡啶酮化合物及其藥物用途 | |
| GB201620066D0 (en) | Solid Pharmaceutical dosage formulations and processes | |
| IL259239B (en) | Oral care compounds and methods | |
| RS65120B1 (sr) | Farmaceutske formulacije i postupci za njihovu upotrebu | |
| GB201601865D0 (en) | Oral dosage products and processes | |
| HUE057788T2 (hu) | Eslikarbazepin szilárd orális dózisformái | |
| HK1245113A1 (zh) | 藥物組合物及其用途 | |
| ZA201801015B (en) | Oral care compositions and methods of using the compositions | |
| ZA201703015B (en) | Solid pharmaceutical composition comprising amlodipine and losartan | |
| PL3288933T3 (pl) | Związki oksindolowe i ich kompozycje farmaceutyczne | |
| IL258304B (en) | Oral treatment compounds and methods of using the compounds | |
| PL3277266T3 (pl) | Doustna stała postać dawkowania amlodypiny i jej zastosowania weterynaryjne |